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Nicotinamide adenine dinucleotide (NAD) is a ubiquitous cofactor participating in numerous redox
reactions. It is also a substrate for regulatory modiﬁcations of proteins and nucleic acids via the
addition of ADP-ribose moieties or removal of acyl groups by transfer to ADP-ribose. In this study,
we use in-depth sequence, structure and genomic context analysis to uncover new enzymes and
substrate-binding proteins in NAD-utilizing metabolic and macromolecular modiﬁcation systems.
We predict that Escherichia coli YbiA and related families of domains from diverse bacteria,
eukaryotes, large DNA viruses and single strand RNA viruses are previously unrecognized
components of NAD-utilizing pathways that probably operate on ADP-ribose derivatives. Using
contextual analysis we show that some of these proteins potentially act in RNA repair, where
NAD is used to remove 20–30 cyclic phosphodiester linkages. Likewise, we predict that another
family of YbiA-related enzymes is likely to comprise a novel NAD-dependent ADP-ribosylation
system for proteins, in conjunction with a previously unrecognized ADP-ribosyltransferase.
A similar ADP-ribosyltransferase is also coupled with MACRO or ADP-ribosylglycohydrolase
domain proteins in other related systems, suggesting that all these novel systems are likely to
comprise pairs of ADP-ribosylation and ribosylglycohydrolase enzymes analogous to the
DraG–DraT system, and a novel group of bacterial polymorphic toxins. We present evidence that
some of these coupled ADP-ribosyltransferases/ribosylglycohydrolases are likely to regulate certain
restriction modiﬁcation enzymes in bacteria. The ADP-ribosyltransferases found in these, the
bacterial polymorphic toxin and host-directed toxin systems of bacteria such as Waddlia also throw
light on the evolution of this fold and the origin of eukaryotic polyADP-ribosyltransferases and
NEURL4-like ARTs, which might be involved in centrosomal assembly. We also infer a novel
biosynthetic pathway that might be involved in the synthesis of a nicotinate-derived compound in
conjunction with an asparagine synthetase and AMPylating peptide ligase. We use the data derived
from this analysis to understand the origin and early evolutionary trajectories of key NAD-utilizing
enzymes and present targets for future biochemical investigations.
Introduction
Recent studies by us and others have shown deep evolutionary
connections between systems involved in cofactor, amino acid
and secondary metabolite biosynthesis and those involved in
modiﬁcations of proteins and nucleic acids.1–4 For example,
the origin of several eukaryotic enzymes that add or remove a
methyl group on lysines and arginines in histones and other
proteins can be directly traced to bacterial pathways involved
in synthesizing peptide-derived antibiotics and siderophores.5
A 2-oxoglutarate-dependent dioxygenase derived from similar
bacterial systems has also spawned the wybutosine hydroxylase/
peroxidase, an enzyme that introduces a key modiﬁcation in
eukaryotic tRNAPhe.6 In a similar vein, multiple components
of the peptide ligation and deubiquitination pathways in the
eukaryotic ubiquitin system show evolutionary relationships
with enzymes involved in diverse bacterial biosynthetic systems
for cofactors (thiamine and molybdopterin), siderophores, anti-
biotics and the amino acid cysteine.1–3,7–10 Enzymes catalyzing
other major forms of peptide tagging of proteins in eukaryotes,
e.g. protein polyglutamylation, polyglycination and tyrosinylation
also display evolutionary connections to peptide ligases involved
in diverse prokaryotic pathways for the biosynthesis of various
antibiotics, the amino acid lysine and cofactors like peptidylated
tetrahydrosarcinapterin (a folate-like pterin derivative) and
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F420 (a ﬂavin-like molecule).1 The generality of this theme is
further reinforced by the evolutionary links between enzymes
catalyzing other forms of peptide tagging of proteins, such as
pupylation and protein arginylation/leucylation, and enzymes
mediating peptide-bond formation, respectively, in the synthesis
of the peptide cofactor glutathione, and a variety of compounds,
such as peptidoglycan and peptide-modiﬁed lipids.1,11 Thus,
the ultimate origin of numerous enzymes involved in covalent
modiﬁcations of proteins and nucleic acids, particularly in
eukaryotic regulatory systems, can be linked to enzymes
catalyzing similar reactions in bacterial biosynthetic systems
specializing in the production of cofactors, amino acids and
metabolites such as antibiotics, siderophores and cell–cell
communication molecules.1,2 These studies, in addition to
elucidating the evolutionary links between biosynthetic pathways
and regulatory modiﬁcations of proteins, have contributed
considerably in identifying fundamentally new regulatory
mechanisms and biosynthetic pathways generating novel
metabolites and also uncovering new components of previously
known pathways.1–4,7,9
Given these connections, we were interested in understanding
the links between the biosynthetic and regulatory pathways
centered on the ancient and ubiquitous metabolite, nicotinamide
adenine dinucleotide (NAD) or its phosphorylated derivative
NADP.12–14 NAD ﬁts particularly well into the above-discussed
patterns because it is both a cofactor for numerous enzymes as
well as a substrate for numerous protein- and nucleic acid-
modifying reactions. As a cofactor it functions as one of the
central redox molecules or hydrogen-carriers in the cell for
reactions catalyzed by diverse oxidoreductases, usually of the
Rossmann fold.7,14 It achieves this by virtue of the facile
transition of the nicotinamide ring between hydrogenated
and dehydrogenated states. As a substrate in protein and
nucleic acid modiﬁcation it supplies the ADP-ribose moiety
for modiﬁcation of side chains of amino acids such as glutamate,
glutamine, lysine, asparagine, cysteine and diphthamide
(a modiﬁed histidine) and arginine and guanine in DNA15–20
(Fig. 1). The most common superfamily of enzymes that
catalyze such reactions unites the ADP-ribosyltransferases
(ARTs), which catalyze the transfer of a single ADP-ribose
moiety to a target molecule, and polyADP-ribose polymerases/
polyADP-ribose transferases (PARPs/PARTs) that transfer
multiple such moieties to form branched or straight chain
ADP-ribose polymers.16,21,22 PolyADP-ribosylation of glutamate
and lysine side chains is an important regulatory modiﬁcation of
eukaryotic chromatin proteins, such as histones, and aﬀects a
variety of cellular processes ranging from DNA repair to
apoptosis.22,23 MonoADP ribosylation of arginine is also an
important modiﬁcation in eukaryotes, for example, in the
regulation of nucleotide-gated ion channels.24 Some of these
ARTs have also been shown to be components of regulatory
systems of bacteria (e.g. the DraT–DraG system25–27) that
modify the activity of proteins such as dinitrogenase reductase
by alternative addition and removal of ADP-ribose from an
arginine side chain. Several bacterial toxins also use a similar
strategy—e.g. the cholera toxin modiﬁes GasR18728—to alter the
behavior of host proteins. Indeed, bacterial toxin ARTs have
evolved a wide range of substrates, such as the Bordetella pertussis
toxin that modiﬁes cysteine, the Clostridium botulinum C3 toxin
that modiﬁes asparagine, the Photorhabdus luminescens toxin
that modiﬁes glutamine29 and the Corynebacterium diphtheriae
toxin that modiﬁes diphthamide.30 In contrast, the lepidopteran
ARTs, such as pierisin, modify the N2 amino group of guanine
in DNA to induce apoptosis.23 Another nucleic acid-modifying
ART is the RNA 20-phosphotransferase KptA/Tpt1, a RNA-
repair enzyme that transfers the 20-phosphate, which is generated
as a result of tRNA splicing and RNA ligase action, to NAD,
resulting in the generation of ADP-ribose 100,200-cyclic diphosphate
(Appr>p) and release of nicotinamide. The rifamycin ART,
which is related to above RNA-processing enzyme, instead
inactivates the antibiotic by ADP ribosylation of a hydroxyl
group on its carbon 23.31
Beyond the ART superfamily, we have recently deﬁned
a novel superfamily of potential bacterial regulatory ADP
ribosyltransferases prototyped by the TM1506 protein, which
belongs to the unrelated deaminase-like fold.32 Another superfamily
of structurally unrelated enzymes, the sirtuins (Sir2-like), which
contain a Rossmann fold, has also been shown to catalyze
monoADP ribosylation of lysines.33–35 A related reaction
in cobalamin biosynthesis, namely the transfer of the
ribose phosphate group from nicotinate mononucleotide to
5,6-dimethylbenzimidazole has also been previously reported.36
However, these enzymes are better known for their alternative
reactions, namely the deacylation (deacetylation, depropionylation,
debutyrylation and decrotonylation) of lysines in proteins for
which they use NAD as an acceptor to catalyze the deacylation
of proteins.37 In the process NAD is split into nicotinamide and
O-acylated ADP ribose (OAADPR) (Fig. 1). These deacylation
reactions are seen across all the three superkingdoms of life and
are particularly important in eukaryotic chromatin in reversing
the acyl modiﬁcations of histones and transcription factors such
as p53.38 In bacteria, they are central to the reversal of the acyl
modiﬁcations of enzymes such as propionyl-CoA synthetase,
which generates the substrate for the acyl modiﬁcation in the
ﬁrst place.39 Both the free and the ligated ADP-ribose moieties
and its various derivatives serve as targets for recognition by
specialized binding domains such as the PARP ﬁnger, a treble
clef domain that binds polyADP ribose,40,41 and the Macro42
and inactive Nudix domains.38 Some Macro domains also
function as enzymes that hydrolyze ADP ribose derivatives,
such as polyADP ribose chains43 or OAADPR.44 The protein
ADP ribosylation systems, in addition to the ARTs, also
contain ADP ribose glycohydrolases (ARGs) and polyADP
ribose glycohydrolases (PARGs; the above-mentioned Macro
domain enzymes) that remove the ADP-ribose moieties from
targets by hydrolyzing the glycosidic bonds.25,45,46
In recent years there has been tremendous progress in terms
of structural and biochemical understanding of ARTs, PARTs,
sirtuins, MACROs and several NAD biosynthesis enzymes.
There have also been several eﬀorts in terms of sequence
analysis leading to the discovery of novel ART superfamily
enzymes19,32,47 and tremendous interest in the connections
between NADmetabolism and the dynamics of heterochromatin
formation, especially in the context of organismal aging.12,33 Our
earlier investigations on the Ub system showed that despite the
numerous advances in the studies on well-understood model
systems there are several novel facets of the biochemistry and
evolution of these systems that can be uncovered from related
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Fig. 1 (A) NAD biosynthesis and salvage pathways and (B) ADP-ribose processing enzymes. pncA: pyrazinamidase/nicotinamidase (EC:
3.5.1.19), isochorismatase-like hydrolase fold; pncB: nicotinate phosphoribosyltransferase (EC: 2.4.2.11), TIM barrel fold, NAPRTase family;
nadC: decarboxylating quinolinate phosphoribosyltransferase (EC: 2.4.2.19), TIM barrel fold, NAPRTase family; pncC: nicotinamide mono-
nucleotide deamidase (EC: 3.5.1.42), anticodon-binding domain fold of class II tRNA synthetases; nadV: nicotinamide phosphoribosyltransferase
(EC: 2.4.2.12), TIM barrel fold, NAPRTase family; nadM: nicotinamide-nucleotide adenylyltransferase (EC:2.7.7.18), HIGH fold; nadR:
bifunctional N-ribosylnicotinamide kinase/NMN adenylyltransferase, HIGH fold adenylyltransferase fused to the C-terminal P-loop domain
(EC: 2.7.1.22/2.7.7.18); nadE: NAD synthetase (EC: 6.3.5.1/6.3.1.5), PP-loop fold; nadK: NAD kinase (EC: 2.7.1.23), diacylglycerol kinase-like
fold; HAD: phosphorylase of the HAD fold; KptA/Tpt1: tRNA 20-phosphotransferase, ADP-ribosyltransferase fold; ART: ADP-ribosyltransferase;
PARP: poly(ADP-ribosyl) polymerase; ARG: ADP-ribosylglycohydrolase; PARG: poly(ADP-ribosyl)-glycohydrolase.
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systems in prokaryotes.1,2,7 Prokaryotes, especially bacteria,
oﬀer a good opportunity for this kind of analysis, given their
highly diversiﬁed metabolic capabilities, availability of large
amounts of genome sequence data and the presence of conserved
operons that reveal functional interactions between genes
involved in the same metabolic pathways.48 Hence, we hoped
that a systematic exploration of the connections between NAD
metabolism and NAD-utilizing protein-modiﬁcation and
nucleic acid-repair systems might help in uncovering new
players and pathways that were not apparent from the studies
on the model systems. With this objective, we performed
comparative genomic and sequence analyses of NAD-utilizing
and synthesizing enzymes. As a consequence, we identify a
novel enzymatic fold that appears to have supplied multiple
distinct families of proteins implicated in NAD/ADP ribose
metabolism in diverse contexts (Table 1). We also identify
several novel domains involved in NAD metabolism, potential
novel pathways for the degradation of NAD, and the synthesis
of an alternative NAD-like molecule with a nicotinamide
moiety (Table 1).
Results and discussion
Layout of the core bacterial NAD-centered pyridine nucleotide
cycle system
Due to the wide utilization of NAD as a substrate both in protein
modiﬁcations, and in the case of bacteria in DNA ligation,49
there is an active system with multiple independent routes to
regenerate by salvaging the byproducts of its utilization.12,13,50–55
While there is diversity in the NAD-centered pyridine nucleotide
cycle across bacteria, especially in terms of the diﬀerent routes of
salvage and overlap with de novo synthesis, the following key
enzymes have been recognized as key players in the pathway
(Fig. 1):12,13,50–55 (1) a multi-domain carboxylating nicotinate/
quinolinate phosphoribosyltransferase (nadC in Fig. 1) capable
of synthesizing nicotinate monophosphate ribonucleotide
(NaMN) from quinolinic acid during de novo synthesis of NAD;
(2) the PncA nicotinamidase that initiates the classical salvage
arm of the pathway by catalyzing the hydrolysis of free
nicotinamide (NM) to nicotinate (NaM); (3) the nicotinate
phosphoribosyltransferase pncB, a TIM barrel enzyme of the
NAPRTase family, that transfers a phosphoribosyl moiety to
nicotinate thus generating nicotinate D-ribonucleotide (NaMN);
(4) a HIGH nucleotidyltransferase (NadD) that adenylates the
nucleotide formed in the prior steps using ATP to form the
dinucleotide; (5) a PP-loop fold NAD synthase (NadE) that
adenylates the carboxyl group of nicotinate using ATP and
subsequently ligates it to ammonia to form a nicotinamide
moiety. Ammonia for this process might be generated by the
action of a nitrilase-like C–N bond hydrolase domain of the
NAD synthetase that hydrolyzes the amide group of glutamine.56
(6) The NAD thus formed might be further phosphorylated by
the NAD kinase, an enzyme with a diacylglycerol kinase-
like fold, on the 20-phosphate of the adenosine ribose to give
rise to NADP. (7) The NAD or nicotinate dinucleotide is
ﬁnally degraded by the action of a Nudix superfamily enzyme,
the NAD pyrophosphatase, to release AMP. Other than the
classical Preiss–Handler pathway outlined above, alternative
pathways for salvage of NAD exist in a number of lineages.
Known examples include the relatively rare non-deamidating
routes, like the salvage of nicotinamide in F. tularensis that is
performed by combined activity of a nicotinamide phospho-
ribosyltransferase (nadV) and a NMN adenylyltransferase
(NadM, in some lineages is also a NaMN adenyltransferase),12,52
or the salvage of ribosylnicotinamide (RNm) by the bifunc-
tional N-ribosylnicotinamide kinase/NMN adenylyltransferase
NadR and its associated RNm transporter PnuC13,53 found in
enterobacteriaceae and some other bacteria. In F. tularensis, the
enzyme NMN synthetase, a paralog of NadE, provides a
unique path for de novo synthesis of NAD from tryptophan
in the absence of NadD via the amidation of NaMN.13,53
In Archaea, NAD metabolism exhibits a lower degree of
variability than in Bacteria, with de novo synthesis of NAD,
when present, proceeding from aspartate to NAD via NaMN
and salvage of nicotinamide and/or nicotinate almost always
Table 1 Summary of the new domain families identiﬁed in this study, respective functional predictions and associated evidence
Family/
clade of
proteins Results and conclusions Supporting evidence/observations
NADAR New superfamily uniﬁes Pfam’s DUF1768 (YbiA) and Phage33.3
with the previously unknown BC4488 family
Sequence similarity, predicted secondary structure, conserved
residues
Predicted ADP-ribose processing activity with YbiA-like members
targeting diﬀusible ADP-ribose derivatives while BC4488 is
predicted to act on conjugated ADP-ribose, perhaps as a
glycohydrolase
Strongly supported by genome context (gene neighborhood,
domain fusion and phylogenetic patterns)
BC4486 New family belongs to the ART fold and predicted
ADP-ribosyltransferase activity
Sequence similarity (transitive PSI-BLAST searches and
HMM–HMM alignment based), predicted secondary structure
and the presence of signature residues
Predicted to be regulatory protein modifying enzymes Strong support from genome context and relationship to
eukaryotic PARPs and NEURL4-like ART domains
ARGA Novel family proposed to be a NAD or ADP-ribose binding domain Conserved sequence signatures and genome context
NUE New family that could adopt a Rossmannoid fold Predicted secondary structure
Predicted to act as an enzyme in NAD/ADP-ribose metabolism, may
be a new ART
Gene neighborhood and phylogenetic distribution
NadE2 Conserved operons found to include an asparagine synthetase,
acyl carrier protein (ACP) and an acyl adenylating enzyme.
Predicted to generate a novel nicotinate and asparagine derived
soluble molecule
Unique conserved gene neighborhoods found in exclusion to
those of the canonical NadE1 genes
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following a deamidating pathway that relies on a single
domain NaNM/NMN adenyltransferase of the NadM family.13
Eukaryotes, on the other hand, may possess a much more
extensive array of NAD biosynthetic pathways than those of
Archaea, including the synthesis of NAD from tryptophan
(vertebrates) or aspartate (plants), the classical Preiss–Handler
deamidating salvage pathway, non-deamidating pathways via
nicotinamide or nicotinate phosphoribosyltransferases and the
pyridine nucleoside salvage.13 While the core NAD system,
outlined above, has been fairly well characterized in terms of
conservation and structural features in diverse organisms
(e.g. see ref. 12, 13 and 50–54), the accumulating data on the
phyletic variation of such systems among organisms piqued
our interest. In particular we hoped to utilize the genomic data to
search for novel domains, which might be functionally associated
with these enzymes that could provide leads pertaining to
unexplored aspects of NAD metabolism (Table 1).
Comparative genomics reveals novel players in NADmetabolism
Identiﬁcation and characterization of the NADAR domain. In
most bacteria a subset of the genes encoding enzymes belonging
to the above-discussed core of NADmetabolismmight be linked
together to form one or more NAD biosynthesis operons. We
used these operons and any potential domain fusions as a
starting point to identify potential novel functional linkages.
As a result, we detected a previously uncharacterized domain
fused to the N-terminus of a NAD synthetase homolog (NadE)
from Ruminococcus albus (GI: 325680741, residues 1–148).
BLAST searches with this uncharacterized N-terminal domain
established its relationship with E. coli YbiA (e-value: 1014),
which is annotated as a domain of unknown function
(DUF1768) in the PFAM database.57 Further transitive
PSI-BLAST searches revealed that this domain is widespread
in several distinct bacterial, eukaryotic and viral lineages
(ESIw). Interestingly, we detected this domain across several
unrelated or distantly related viruses, which include ssRNA
nidoviruses (e.g. Gill-associated virus and yellow head virus of
shrimps), and several large DNA viruses namely, iridoviruses
(e.g. Invertebrate iridovirus 3), ascoviruses (Diadromus pulchellus
ascovirus 4a), Acanthamoeba polyphaga mimivirus and certain
caudate bacteriophages (e.g. phage T4). Some of the viral
versions, such as those typiﬁed by the T4 phage gp30.3 protein,
have been previously classiﬁed in the PFAM database as an
uncharacterized family labeled as ‘‘Phage_30_3’’. Thus, our
searches established that the DUF1768, the Phage_30_3 and
several previously uncharacterized versions can be uniﬁed into a
single superfamily prototyped by E. coli YbiA. Additional
iterative searches initiated with the gp30.3 from enterobacterio-
phage RB43 (GI: 66391541) not only conﬁrmed the relationship
of the DUF1768/gp30.3 families, but also recovered hits with
border-line statistical signiﬁcance (e E .017; fourth iteration)
from bacteria and phages, which displayed the same highly
conserved motif as that found in the above YbiA-like proteins
(Fig. 2). A search initiated with the best matching member of this
set of divergent sequences (Kitasatospora setae KSE_10250,
gi: 311894452) recovered several additional homologs from
diverse bacteria, eukaryotes and bacteriophages (e.g. Ralstonia
phage RSL1). Interestingly, we observed homologous proteins
in several distinct amoeboid eukaryotes (e.g. the heterolobosean
Naegleria gruberi and the slime molds Dictyostelium fasciculatum
and Polysphondylium pallidum) and the large nucleo-cytoplasmic
DNA viruses (NCLDVs) that infect amoebae namely, the
Lausannevirus and Marseillevirus. Proﬁle–proﬁle align-
ments of Hidden Markov Models (HMM) using HHpred
conﬁrmed the relationship between these proteins and the
YbiA-like proteins (p = 1012; 96.27% probability). This
indicated that in addition to the originally deﬁned YbiA-
like proteins the superfamily also contains a second major
group deﬁned by the proteins recovered in the above-described
searches.
Given the potential association with NAD metabolism we
named this superfamily of domains the NADAR superfamily
(due to its linkage to ‘‘NAD and ADP-ribose’’). Both multiple
sequence alignments (Fig. 2) and similarity based clustering
using the BLASTCLUST program indicated that the two
groups deﬁned two distinct families within the NADAR
superfamily. We named the ﬁrst family including YbiA and
the phage gp30.3 proteins the YbiA family, while we termed
the second one the BC4488 family after an exemplar from
Bacillus cereus (gi: 30022528). A NMR structure of YbiA
protein produced by the Northeast Structural Genomics program
(pdb: 2b3w) provided us a structural template for reﬁning and
interpreting the multiple alignment of the NADAR superfamily
(Fig. 2). The NADAR domain displays a unique fold, which is
dominated by an array of ﬁve core helices ﬂanked by two small
sheets, each with a couple of strands. Three sequence motifs are
present across the superfamily: (1) a ‘‘hSph’’ signature (where ‘‘p’’
is polar and ‘‘h’’ is hydrophobic) at the C-terminus of an isolated
310 helix occurring after the ﬁrst strand; (2) the ‘‘ExhhbxxK’’
motif which is characteristic for the superfamily (where ‘‘s’’ is a
small and ‘‘b’’ a bulky residue, typically glutamine) in the ﬁrst
a-helix; (3) a highly conserved charged residue in the last strand
which is almost always a histidine in gp30.3-like proteins, a
glutamate in the rest of the YbiA family, and an aspartate in
the BC4488 family (Fig. 2). Mapping of the conserved residues
onto the structure of YbiA shows that most of them constitute a
network of hydrophobic or polar contacts around a central cavity
that are likely to stabilize the fold (Fig. 2; e.g., the acid residue in
the last strand shares a hydrogen bond with the serine residue of
the ﬁrst motif). However, some residues, like the characteristic
conserved lysine of the second motif, have their side chains
exposed inside the cavity. These features suggest that the
NADAR domain might possess the ability to bind small
molecule ligands and either function as a binding protein or
an enzyme in the context of NAD metabolism.
The YbiA family and NAD utilization. We utilized contextual
information from gene neighborhoods and domain architectures
to further test the hypothesis of the involvement of NADAR
domains in NAD metabolism and to better understand their
functions (Fig. 3). As a result, we found that the YbiA family of
NADAR domains is most frequently associated in predicted
operons with a gene encoding the enzyme RNA 20-phospho-
transferase (KptA/Tpt1), which in the archaeo-eukaryotic
lineage ‘‘cleans up’’ spliced tRNAs by transferring the
20-phosphate to NAD (Fig. 1). While the conventional bacterial
tRNA maturation process does not require KptA, the enzyme
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can catalyze the same reaction as its archaeo-eukaryotic
cognates in vitro and complement knockouts of the homologous
TPT1 in yeast.58 This association is also recapitulated in certain
eukaryotes, e.g. the basal member of the animal-lineage
Capsaspora owczarzaki (gi: 320163643; Fig. 3), where the
YbiA domain is combined in the same polypeptide as the
KptA module, though they are separated by intervening
leucine-rich repeats. YbiA family members are also frequently
Fig. 2 Multiple sequence alignment and structure of the NADAR domain. (A) Cartoon and surface representations of the structure of the YbiA
protein from E. coli (PDB: 2b3w), with most highly conserved residues represented as spheres. (B) Multiple sequence alignment of selected
representatives of the NADAR domain. Sequence identiﬁers were derived from the oﬃcial gene name or locus tag, a species code and NCBI’s GI
number for the protein, separated by underscores (see Tables S1 and S2 (ESIw) for species codes and sequence accession numbers).
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associated (both those with and without an associated KptA-like
gene; Fig. 3) with a gene coding for a Nudix phosphohydrolase,
which is most closely related to the ADP-ribose pyrophospha-
tases that catalyze the hydrolysis of the NAD derivative ADP-
ribose to AMP and ribose-5-phosphate59 (Fig. 1). In several
bacteria these predicted operons extend further to include other
genes coding for one or more enzymes such as nicotinamidase,
ribose-phosphate pyrophosphokinase, nicotinamide phospho-
ribosyltransferase, nicotinamide riboside kinase and nicotinamide
nucleotide adenylyl transferase (Fig. 3). These enzymes belong
to the salvage pathway to process the nicotinamide moiety or
recover NAD from its byproducts, when nicotinamide is
released from reactions resulting in the transfer of ADP-ribose
to target moieties (Fig. 1).12 The more extended operons might
also code for two distinct families of Macro domains and
ADP-ribose glycohydrolases (ARGs) that cleave the covalent
bond between ADP-ribose and the target moieties to release
ADP-ribose (Fig. 1 and 3). One of these distinct families of
Macro domains (formerly DUF2263 in the PFAM database)
has recently been shown to function as a polyADP ribose
glycohydrolase (PARG) (Fig. 1).43 The second family is
the classical Macro domain, which includes members that
bind ADP ribose derivatives and hydrolyze ADP-ribose
10-phosphate (Appr1p) or OAADPR (Fig. 1 and 3).43,60 In
some cases YbiA might also be fused to a classical Macro
domain and an ARG domain (e.g. Ruminococcus gi: 291543774;
Fig. 3). Some operons encoding a PARG-type Macro domain
protein (e.g. Verrucomicrobium) are more elaborate and
include further RNA-repair enzymes such as the polynucleotide
kinase and Thg1, the 50–30 RNA polymerase (Fig. 3). Most
remarkable are certain large gene clusters in bacteria such as
Kordia algicida and Chryseobacterium gleum, which combine a
YbiA-like gene with those coding for enzymes involved
in nicotinamide salvage, several NAD-utilizing enzymes
Fig. 3 Genomic context and domain architectures for the NADAR domain, BC4486-like ART family and the DraT/DraG system from
Azospirillum sp. B510. In all panels, arrows represent genes in a given neighborhood and all other geometric ﬁgures represent domains in a single
polypeptide chain. Glyphs are not drawn to scale but may be resized to accommodate the gene structural and/or functional annotation. When
present, genes names are the same as in Fig. 1 otherwise they correspond to names extracted from the organism’s annotation in GenBank or to
matching PFam domain names. Additional short names or acronyms: RM, restriction-modiﬁcation system enzyme; RM_TRD, restriction-
modiﬁcation target recognition domain; RM_MT, restriction-modiﬁcation methyltransferase; RM_RE, restriction-modiﬁcation endonuclease;
PP2A: PP2A-like phosphatase; NT5C: 50-nucleotidase; PNK: polynucleotide kinase; ARGA: ADP-ribosylglycohydrolase-associated domain;
NADA: NADAR domain; NUE: Rossmann fold NAD-utilizing enzyme; Mbetalac: metallobetalactamase; 2OGFeDO: 2-oxo-glutarato iron-
dependent dioxygenase; RGG: arginine- and glycine-rich RNA-binding repeat; ExoEndoNuc: nuclease; GST: glutathione S-transferase;
Inac_Deamin: inactive deaminase; RossmannDeH: Rossmannoid dehydrogenase.
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(KptA, a sirtuin that is distinct from the usual CobB-like
deacylase and multiple ARTs), ARGs and a classical Macro
domain protein (Fig. 3).
The above associations corroborate the link between the
YbiA family of NADAR domains and NAD metabolism. The
associations with KptA, Macro superfamily, ADP-ribose
pyrophosphatase, ARG, sirtuin, and nicotinamide salvage
and degradation enzymes suggest that the action of the
NADAR domain is associated with the utilization of NAD
to generate ADP-ribose derivatives. More speciﬁcally, these
associations point towards NADAR itself interacting with
ADP-ribose derivatives. Further, the strong association with
KptA suggests that one of the major roles of the YbiA family
of NADAR domains is likely to occur in the context of
RNA-processing. This possibility receives further support from
the domain architectures of the eukaryotic members of this
family (Fig. 3): one conserved fusion combines the NADAR
domain with a RNA-binding RRM and phosphopeptide-
binding FHA domains in several chromalveolate eukaryotes
(e.g. Plasmodium), whereas other proteins combine the NADAR
domain with RNA-binding domains, such as the LA and
ribosomal protein L1-like domains and the low-complexity
RGG repeats (Fig. 3). The C. elegans YbiA homolog irg-1
(gi: 351020506) was recently recovered as being highly induced
by bacterial pathogens.61 Given the links of the eukaryotic
NADAR domains to NAD consumption in the context of
RNA-processing, it is conceivable that this RNA-related function
is utilized in pathogen response in C. elegans. Interestingly, unlike
most other eukaryotes, nematodes possess multiple paralogous
NADAR proteins of the YbiA family, including versions with up
to three tandem repeats in the same polypeptide (C. elegans
C23G10.8; Fig. 3). The presence of a YbiA family NADAR
domain in the polyproteins of RNA viruses is also of interest in
this regard because it mirrors the earlier reported occurrence of
Macro and 2H phosphoesterases (which hydrolyze 20,30-cyclic
phosphates and Appr>p) in diverse RNA and retroviruses.60,62,63
Thus, it is conceivable that the NADAR domains also perform
functions comparable to these enzymes in the above viruses.
Finally, the presence of YbiA-like NADAR domains (including
phage T4 gp33.3-like proteins) in NCLDVs and several bacterio-
phages may also be linked to their possession of functionally
linked RNA-repair enzymes that include the 2H phosphoesterases
and RNA ligases. Given that endoRNAses that do not use a
metal-dependent catalytic mechanism tend to generate 20,30-cyclic
phosphate,64,65 repair of such ends is likely to involve NAD-
utilizing enzymes such as KptA. In archaea and eukaryotes such
cyclic phosphates emerge naturally as a part of cellular process
such as tRNA splicing, rRNA and snRNA processing;66–69 hence,
it is conceivable that the NADAR domains, like the MACRO
and 2H domains, participate in such processes. While bacteria do
not possess comparable RNA splicing processes, their tRNAs
and other RNAs are targets of a multitude of toxic endoRNAses
coming from classical type-II toxin–antitoxin systems, plasmid
encoded bacteriocins, and a recently discovered class of chromo-
somal polymorphic toxins.70–72 Similarly, DNA viruses are
subject to defensive cellular responses that cleave tRNA and
other virally encoded RNAs that could result in 20-phosphate-
containing products.65,73 Eukaryotic RNA viruses also face
host endoRNAses and also in several cases possess their own
endoRNAses that are related to the endoRNAse domains of
bacterial toxins (e.g. the EndoU RNase), which can generate
20-phosphate-containing cleavage products.70,74,75 In all these
cases, RNA repair via a KptA-dependent mechanism is likely to
generate ADP-ribose derivatives, which when further processed
by the NADAR domain might result in improvement of the
overall eﬃciency of repair. Alternatively, the DNA viral gp33.3
like proteins could function in conjunction with the ADP
ribosyltransferases encoded by several of these viruses, such
as the T4 enzyme which modiﬁes the host RNA polymerase
a-subunit.76
The BC4488 family and a previously uncharacterized ART
family deﬁne a novel NAD-dependent modiﬁcation system. We
observed that the bacterial versions of the second distinct
family of NADAR domains, the BC4488 family, in contrast
to the above-described YbiA family, showed strong operonic
association with genes encoding an uncharacterized family
(hereinafter BC4486 family, after the gene linked to BC4488)
of conserved proteins (Fig. 3). Proﬁle–proﬁle comparisons
revealed that the BC4486 family of proteins belonged to the
ART superfamily (p= 107; 95% probability), which include
KptA, ARTs and PARPs. Structure prediction using this
multiple alignment presented an a + b fold with 6 core
strands, which is congruent with the secondary structures of
the known members of the ART superfamily (Fig. 4).16–21,31,47
Comparison of the multiple alignment of this family with
those of other members of the ART superfamily revealed an
HxT signature in the ﬁrst strand, a conserved Y in the second
strand and a QxE signature in the 5th strand. These positions
correspond to the key catalytic motifs of the superfamily that
tightly envelop the NAD in the active site.16–21,31,47 The
presence of the acidic residue in the 5th strand (i.e. the E)
and a large insert between the 4th and 5th strands and the
absence of a N-terminal winged HTH domain distinguish
the classical ARTs which modify proteins and bases from
the KptA-like enzymes, which act on 20-phosphates.67 The
above features shared with classical ARTs strongly suggests
that the BC4486 family is likely to modify proteins or bases
and not RNA termini. Further, the active site in the majority
of members of this family assumes the H–Y–E type pattern
(based on the conserved residues from the above-mentioned
signature; Fig. 4), which is a distinguishing feature of a clade
within the ART superfamily that unites the diphthamide-speciﬁc
ARTs (e.g. diphtheria, cholix and Pseudomonas aeruginosa
exotoxin A toxins) and the eukaryotic PARPs. These enzymes
are currently known to modify diphthamide, glutamate/aspartate
and lysines.16–21,31,47 Thus, they are distinct from the ART
clade, which is characterized by a R–S–E type active site that
modify residues such as arginine (further deﬁned by an ExE
signature associated with 5th strand), cysteine and asparagine
and nucleic acid bases.16–21,31,47 Given that diphthamide is
unique to the eukaryotic elongation factor EF2, it is possible
that the BC4486 family of ARTs modiﬁes lysines or glutamates,
just like the eukaryotic PARPs. Some of the predicted
BC4488 operons, in addition to the novel ARTs also code
for ARGs (Fig. 3). Thus, even the BC4488 family of NADAR
domains can be linked to the NAD metabolism by virtue of
their functional connection to this novel family of ARTs.
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Fig. 4 Multiple sequence alignment and structure of ADP-ribosyltransferase-like enzymes (ART fold). (A) Multiple sequence alignment of the
BC4486-like family, a new ART. (B) Schematic topology diagrams and cartoon representation of the structures of KptA and human tankyrase 2.
(C) Multiple sequence alignment of representatives of the RNA 20-phosphotransferase KptA/Tpt1 family. Sequence identiﬁers were derived from
the oﬃcial gene name or locus tag, a species code and NCBI’s GI number for the protein, separated by underscores (see Tables S1 and S2 (ESIw)
for species codes and sequence accession numbers).
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However, they do not display most of the other associations
observed in the YbiA family (e.g. Nudix or NAD salvage
enzymes), suggesting that the two families of NADAR domains
have evolved diﬀerent biochemical capabilities.
To better understand the role of the BC4486 family of novel
ARTs, we performed a reciprocal gene neighborhood analysis
to determine their potential operonic associations. Consistent
with the above results, we observed that the reciprocal analysis
recovered the BC4488 family of NADAR domains as one of
the most strongly associated neighbors of the BC4486-like
ARTs (Fig. 3). Interestingly, most of those BC4486-like ART
genes, which lacked a BC4488 family NADAR gene in their
neighborhood, were associated with either a gene encoding a
Macro domain or a classical ARG (Fig. 3). Thus, there is a
mutually exclusive relationship between the BC4488 family
NADAR genes and the Macro genes with respect to the
BC4486-like ARTs. In some cases, these ARTs also displayed
either C-terminal or N-terminal fusions to this Macro domain
(Fig. 3). This gene organization suggests that the Macro and
the BC4488 family NADAR are potentially functionally
equivalent and represent structurally unrelated but catalytically
equivalent enzymes. Further, in some cases instead of either the
Macro or the BC4488 family genes there are genes encoding a
3rd structurally unrelated but catalytically comparable protein,
i.e. ARG, in an equivalent position (Fig. 3). Hence, by virtue of
this positional equivalence in the operons we suggest that
the BC4488 family of NADAR and the Macro domains that
co-occur with the BC4486-like ARTs might function as ARGs
or PARGs. This is also supported by the fact that this gene
organization is reminiscent of the gene organization of the
DraG/DraT systems of nitrogen-ﬁxing photosynthetic bacteria,
which encode a pair of enzymes with opposing catalytic
activities, namely an ADP-ribosyltransferase (DraT) and an
ARG (DraG) which together form a regulatory switch for the
dinitrogenase reductase (Fig. 3). Moreover, recently structural
studies have conﬁrmed that the PARGs are distinct clades of
the Macro domain superfamily.43 Thus, we predict that the
BC4486 ARTs and the linked ARGs, PARGs or NADAR
proteins constitute regulatory enzyme pairs, which might
respectively ADP-ribosylate and de-ADP-ribosylate target
proteins. Given this association, we investigated if there might
be any other pairs that are functionally analogous to the
DraG/DraT-like systems and those with BC4486-like ARTs.
Consequently, we uncovered a diverse group of ARTs,
primarily with R–S–E type active site conﬁguration from
proteobacteria, ﬁrmicutes and actinobacteria that were
coupled in a predicted operon with ARGs, with the ART gene
always preceding the ARG gene. Interestingly, all these examples
appeared to be secreted ARTs that are either delivered via
the regular type II secretory pathway, or the type VI system
(in proteobacteria with associated Phage tail/VgrG-like genes)
and the ESX/type VII system (in actinobacteria with
N-terminal ESAT-6/WXG-like domains).32,70 Importantly, these
ART domains always occur as the C-terminal-most domain and
in several cases might be preceded by long repetitive structures
such as RHS/YD repeats (e.g. gi: 221200352 from Burkholderia
multivorans) and proline/glycine rich low complexity stretches
in actinobacteria (e.g. 134103275 from Saccharopolyspora
erythraea). This operon organization and domain architecture
indicates that these ARTs are toxins belonging to a recently
described class of polymorphic toxins primarily implicated in
intraspeciﬁc competition in bacteria, in which the C-terminal
toxin domain is delivered into rival target cells.32,70,77 Thus, in
this case the ARG is an immunity protein that protects the
producing cell against its own ART toxin. Thus, the use of
genomically linked opposing ART and ARG pairs appears to
be widespread in bacteria across a thematically diverse group
of systems.
To better understand the potential targets and functions of
the novel BC4486-BC4488-like ART-ARG systems we further
examined their genomic context for any additional conserved
associations. One persistent theme that emerged was the
association of versions of the system with both the BC4488
family of NADAR domains and the Macro domains with
restriction-modiﬁcation (R–M) operons in actinobacteria,
cyanobacteria, bacteroidetes and gamma-, delta- and betaproteo-
bacteria (Fig. 3, ESIw). Often this predicted ART–ARG gene
pair was embedded right within a R–M operon that additionally
encoded restriction endonucleases (REases), modiﬁcation
methylases (MTases) and DNA helicases. Interestingly, in
Ilyobacter, a BC4488 NADAR domain is fused to the MTase
of the RM system with which it is associated and is upstream
to genes coding for nuclease and helicase genes (Fig. 3). In
Faecalibacterium the BC4488 NADAR domain is also fused to
a previously unrecognized REase (DUF1887; ESIw). These
associations suggest that across diverse bacteria targets of
these predicted ART–ARG systems are diﬀerent components
of R–M systems. This raises the remarkable possibility that the
activity of these R–M systems might involve a further level of
control that is under the alternative modiﬁcation/de-modiﬁcation
of their component proteins.
Beyond these bacterial ART–ARG systems, the BC4488-like
NADAR domains are present in diverse amoeboid eukaryotes
(e.g. Dictyostelium and Naegleria) as well as NCLDVs that
infect amoebae. Outside of the ART–ARG systems, more
divergent BC4486-like ARTs are present in large eukaryotic
DNA viruses, including baculoviruses, e.g. Agrotis segetum
granulovirus, and NCLDVs such as Invertebrate iridescent
virus 6 and Diadromus pulchellus ascovirus 4a. Divergent
BC4486-like ART domains are also found in a potential toxin
secreted by the intracellular chlamydia-like pathogen of animals
and amoeboid eukaryotes,Waddlia chondrophila (gi: 337292305).
Another group of ARTs related to the BC4486-like ARTs are
also found in tailed bacteriophages such as Vibrio phage KVP40
and the Bacillus phage G. Interestingly, these ARTs have
undergone a lineage expansion in theBacillus phageG (10 paralogs)
and the nanohaloarchaeo Haloredivivus (at least 8 paralogs;
ESIw). We observed that eukaryotes also possess a distinct
clade of BC4486-related ARTs, which in sequence searches
appear to provide a link between the above-described BC4486-
like proteins and the classical PARPs, which also belong to the
H–Y–E clade. These eukaryotic versions are typiﬁed by
the C-terminal-most domain of the human NEURL4 and
Drosophila Bluestreak proteins (e.g. gi: 53829370; region
1408–1562; see ESIw for complete alignment). Homologous
domains are found in most animal lineages (except nematodes),
choanoﬂagellates, slime molds, entamoebae, and alveolates,
and are typically fused to several other domains such as
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neuralized repeats, ubiquitin, WWE, and MORN-repeats.
Notably, representatives of this clade of ART have undergone
independent lineage speciﬁc expansions in slime molds, sponges,
crustaceans, amphioxus and ciliates and these versions might be
fused to either ubiquitin or MORN repeats. A functional link
between these ARTs and the ubiquitin system is also suggested
by a recent study indicating that NEURL4 functions with the
ubiquitin E3 ligase HERC2 in maintaining normal centrosomal
morphology.78 Additionally, the WWE domain found fused to
an ART of this clade is also a common domain shared by
ADP-ribosylation and ubiquitination systems.79 This led us to
the proposal that ADP-ribosylation of component proteins, in
conjunction with ubiquitination, might have a role in centro-
somal assembly. The shared presence of several BC4486-like
ARTs and BC4488-like NADAR domains in large DNA
viruses, intracellular parasites and in some cases also the
eukaryotic hosts of the former parasites, and their lineage-
speciﬁc expansion in several eukaryotes, suggests that these proteins
might have been further adapted for ADP-ribosylation-related
functions in the context of host–pathogen interactions. On the
other hand, some of the conserved eukaryotic versions like
NEURL4 are likely to have been recruited as regulators of
eukaryote-speciﬁc functions such as centrosome assembly.
Comparison with Macro, ARG and ART domains and a
general proposal for the catalytic activity of NADAR domains.
The above analysis suggesting that the BC4488 family of
NADAR domains function as ARGs or PARGs is consonant
with the conclusion that the YbiA family of NADAR domains
is likely to operate on ADP-ribose derivatives. Indeed, given the
extreme divergence between the two families (Fig. 2) it is
conceivable that the two have somewhat diﬀerent biochemical
activities. This situation can be compared to some of the other
enzymes related to NAD and ADP ribose metabolism, wherein
divergent members displaying a common structural fold with a
conserved active site location might support distinct biochemical
activities involving related molecules. For instance, the Macro
domain fold includes several distinct activities, which operate on
diﬀerent ADP ribose derivatives such as O-acyl ADP ribose,
polyADP ribose and 100-ADP ribose phosphate.43,44,60 Likewise,
members of the ARG fold have both ADP-ribose glyco-
hydrolase and O-acyl ADP-ribose deacylating activity
(e.g. human ARH3).25,80,81 Similarly, the ART domains in
addition to ADP-ribosylating amino acids, antibiotics, bases
and 20-phosphate RNA termini also function as NAD hydrolases
that generate nicotinamide and ADP ribose (e.g. rat ART2).21,67,82
This situation is also seen in the NAD biosynthesis/salvage
system wherein the homologous phosphoribosyltransferases
of the TIM barrel NAPRTase family, nadC, nadV and pncB,
respectively, act on distinct but related substrates such as
quinolinate, nicotinamide and nicotinate.13 Thus, we suggest
that the YbiA and the BC4488 families of NADAR domains are
likely to catalyze distinct reactions on ADP ribose derivatives.
Given the operonic association with KptA, we suggest that some
of the YbiA-like proteins might process the 100–200ADP ribose
cyclophosphate, which is then cleaved further into AMP and
ribose 1-phosphate by the associated Nudix enzymes. It is also
conceivable that some YbiA-like proteins might act on O-acyl
ADP ribose—thus the YbiA family is seen to include enzymes
that speciﬁcally help in the processing of diﬀusible ADP-ribose
derivatives emerging from NAD-utilization, while the BC4488
family primarily acts on protein-linked ADP ribose moieties.
This might explain the observation that, unlike the BC4488
genes, which have a mutually exclusive phyletic distribution with
respect to the ARG-type Macro domains, the YbiA family
sometimes co-occurs with PARG genes: the YbiA type
NADAR domain in this case might help in cleaving the
smaller multi-ADP-ribose units released by PARG action.
The above observations might also help explain a domain
architecture involving a NADAR domain of the YbiA family
from gammaproteobacteria, wherein it is combined with a
GTP cyclohydrolase II domain (Fig. 3). These versions show
none of the above-described gene neighborhood associations.
The classical GTP cyclohydrolase II catalyzes the ﬁrst step in
riboﬂavin biosynthesis;83 however, the version of the domain
fused to the NADAR domain represents a distinct paralog and
these do not show any contextual association with riboﬂavin
biosynthesis. Recently, a distinct function has been proposed for
a version of the GTP cyclohydrolase II in uracil degradation, by
potentially catalyzing the opening of the uracil ring.84 Based
on this precedent, we suggest that the GTP cyclohydrolase II
version fused to NADAR could play a comparable role in a
nicotinamide degradation system involved in the degradation of
NAD derivative or its byproducts like ADP-ribose derivatives.
Other novel domains with potential roles in interacting with
NAD and ADP ribose derivatives. The above analysis of
the NADAR gene neighborhoods and associated domain
architectures uncovered two additional, previously uncharac-
terized, conserved globular domains that showed multiple
connections to these NAD-utilizing systems. The ﬁrst of these
families is prototyped by a small a+ b domain around 115 aa
found in representatives of most major bacterial lineages
(e.g. Oter_1044 from Opitutus terrae; ESIw). We observed that
this domain was fused to the PARG-type Macro domain
found in the NADAR operon from Verrucomicrobium
(gi:171913882; Fig. 3). The same domain also occurs in the
above-described large NAD-utilization cluster from Kordia
algicida OT-1 (gi:163754443; Fig. 3). Furthermore, it is also
found fused to the C-terminus of an ARG domain in Nostoc
punctiforme (gi: 186681810). Given its fusion to two distinct
ADP-ribosylglycohydrolase domains, we named this domain
the ARG-associated (ARGA) domain. Gene neighborhood
analysis indicated that, like the YbiA family of NADAR
domains, genes encoding proteins with the ARGA domain
are found associated in predicted conserved operons with genes
coding for Nudix ADP-ribose pyrophosphatase, classical
Macro domains, ARGs, KptA and diverse NAD synthesis
enzymes (Fig. 3; ESIw). These associations support a role for
the ARGA domain in connection to NAD and ADP-ribose
derivatives. Given its small size and the absence of universally
conserved charged or polar residues suggestive of catalytic
activity, it is likely that the ARGA domain is a novel NAD or
ADP-ribose binding domain. By sensing these metabolites it
could potentially regulate fused or physically associated catalytic
domains that utilize NAD or ADP-ribose derivatives.
The second family is deﬁned by an a/b domain of about 190 aa
that always occurs as a standalone protein. A multiple alignment
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of this domain shows that it has several nearly universally
conserved charged and polar residues, indicating that it is
likely to be an enzyme (ESIw). Its predicted secondary structure
reveals a regular pattern of ﬁve alternating strands and helices
with a highly conserved glutamine between strand 1 and helix 1
and a DxE motif at the C-terminus of strand-4 that are likely to
constitute the active site of this enzyme. Furthermore, this
arrangement is reminiscent of the positioning of active site
residues in the Rossmannoid folds suggesting that it might
adopt such a a/b conﬁguration.7,85 Its presence in the large
NAD-utilizing cluster from Kordia (Fig. 3) suggests that it
might utilize NAD, just like the other NAD-utilizing enzymes
in the cluster (e.g. the Sirtuin and ART). This is further
supported by its operonic association with Nudix ADP-ribose
pyrophosphatase, independently of the NADAR operons
(ESIw). We accordingly term this domain the NAD utilizing
enzymatic (NUE) domain. Given its widespread presence in
bacteria and also several eukaryotic lineages including certain
animals, amoebozoans and heteroloboseans (ESIw), it would
be of interest to investigate if it might function as a novel
ADP-ribosyltransferase.
Genomic analysis reveals a biosynthetic pathway for a novel
nicotinamide containing metabolite
Several archaea, proteobacteria, planctomycetes, actinobacteria,
chloroﬂexi and cyanobacteria contain a second paralog of the
NAD synthetase (Fig. 5, ESIw). Gene context analysis reveals
that the paralog involved in NAD synthesis is typically
distinguished by its routine occurrence in operons encoding
other NAD salvage/biosynthesis enzymes such as the nicotinate
phosphoribosyltransferase, adenylyl transferase, Nudix ADP-
ribose pyrophosphatase, glutamine synthetase and its regulatory
protein PII.12,13,50,52,53 However, the second paralog in these
organisms displays a very distinct gene neighborhood context
that never contains conventional NAD salvage/biosynthesis
genes (Fig. 5). Instead, these conserved neighborhoods are
typiﬁed by three other genes that almost always co-occur with
the paralogous NAD synthetase gene. These genes encode an
asparagine synthetase, an acyl carrier protein (ACP) and an
acyl adenylating protein similar to those that activate acyl
groups in fatty acid and non-ribosomal peptide synthesis
(Fig. 5, ESIw).86 In several organisms this asparagine synthetase
Fig. 5 Upper panel: genomic context of the paralogous NAD + synthetase (nadE) and its associated acyl adenylating enzyme. Lower panel: a
speculative scheme of reaction steps inferred based on the conserved gene neighborhood. AsnB: asparagine synthetase; ACP: acyl-carrier protein;
ANL: acyl adenylating proteins of the acetyl-CoA synthetase-like fold; Hexapep_OACET: LpxA-like acyltransferase; PKS: polyketide synthase;
UPpGP: glycosyltransferase.
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is a distinct second paralog, suggesting that the pathway deﬁned
by these predicted operons utilizes a dedicated asparagine
synthetase. These observations combined with the absence of
other NAD salvage/biosynthesis genes in these predicted operons
suggest that this NAD synthetase is deployed along with other
enzymes in the synthesis of a distinct metabolite that combines
asparagine and NAD moieties.
Although, at this point, we have to rely solely on the
genome neighborhood information described above to infer
the metabolic pathway associated with NadE2, it is tempting
to speculate on its nature. We propose the following tentative
biochemical scheme for the action of enzymes encoded by this
system (Fig. 5): given the close relationship of the asparagine
synthetase to conventional asparagine synthetases and the fact
that in some organisms it might be the only asparagine
synthetase encoded by the genome, we propose that it indeed
synthesizes asparagine from aspartate and glutamine. The
carboxyl group of this asparagine is then probably activated
by the acyl adenylating protein and conjugated to the ACP,
which serves as the scaﬀold for the synthesis of the ensuing
product. Given that the NAD synthetase is closely related to
the classical NAD synthetase in its adenylating PP-loop
ATPase domain, we suggest that it is indeed likely to adenylate
the carboxyl group in the nicotinate moiety just like the
conventional NAD synthetases. However, the majority of
these NAD synthetases lack an ammonia-generating nitrilase-
like domain.12 Hence, we propose that these paralogous NAD
synthetases upon adenylating nicotinate perhaps instead ligate
its adenylated carboxyl group to the free NH2 group of the
ACP-linked asparagine (Fig. 5). Thus, this system might
generate an asparaginylated NAD or NMN, which might then
be subject to further modiﬁcations. Evidence for this comes
from the observation that several of these neighborhoods
encode additional enzymes such as glycosyltransferases,
O-acyltransferases of the hexapeptide repeat superfamily and
in certain cases additional non-ribosomal peptide ligases with
condensation domains (Fig. 5). This suggests that the basic
metabolite might be further glycosylated and acylated or even
combined with additional amino acid moieties. If the modiﬁed
nicotinamide ring proposed to be generated by this pathway
retains its properties then it is conceivable that the metabolite
synthesized by these systems might function as a soluble
antioxidant comparable to the peptide antioxidants, such as
glutathione, mycothiol and bacillithiol.11,87,88 However, given
the extensive modiﬁcation, it is also possible that it is a
secondary metabolite that has biochemical properties entirely
distinct from NAD or NADP and has an unrelated role.
Evolutionary implications and general conclusions
Our investigation of the NAD metabolism system has helped
in uncovering several previously uncharacterized enzymes and
at least one potential NAD/ADP ribose-binding domain. Our
ﬁndings also have considerable implications when placed in
the broader context of the evolutionary history of NAD-
dependent and NAD-utilizing enzymes. Comparative genomics
suggests that the most ancient group of NAD-dependent
enzymes is that possessing the classical Rossmann fold.89,90
One group of classical Rossmann fold enzymes, typiﬁed by
glyceraldehyde-3-phosphate dehydrogenase, does not further
process NAD as a substrate, but merely uses it as a cofactor
for catalyzing redox reactions.14,90 The presence of these
enzymes in the core gluconeogenetic/glycolytic pathway and
their nearly universal presence across the three superkingdoms
of life suggest that such NAD-dependent classical Rossmann
fold enzymes were already present in the last universal common
ancestor (LUCA).89,91 A second group of enzymes with the
classical Rossmann fold includes the sirtuins, deoxyhypusine
synthase and the NAD–NADP transhydrogenases, which display
a similar topology as the former,92,93 but bind NAD in the reverse
conﬁguration relative to the former. The presence of the
deoxyhypusine synthase in the common ancestor of the archaeo-
eukaryotic lineage and the presence of a NAD–NADP
transhydrogenase-like enzyme in the common ancestor of
the bacterial lineage suggests that at least one NAD-dependent
dehydrogenase with the second version of the Rossmann fold
was present in the LUCA.89 Consequently, it may be argued
that dehydrogenases displaying versions of the classical
Rossmann fold with the two distinct NAD-binding modes
had already diverged from each other prior to the LUCA.
Sirtuins are found across three superkingdoms of life,
with several paralogous versions in eukaryotes. Phylogenetic
analysis suggests that there was a notable diversiﬁcation of
sirtuins in bacteria and the eukaryotic versions were acquired
on several occasions from bacteria, followed by further
eukaryote-speciﬁc radiations (ESIw).94 In contrast, majority of
archaeal sirtuins from euryarchaea, crenarchaea and korarchaea
appear to form a slow-evolving monophyletic clade. Based on
this and the widespread distribution of sirtuins in both bacteria
and archaea, we infer that an ancestral sirtuin was likely to have
been present in the LUCA. While belonging to the second
group of classical Rossmann fold enzymes, which includes
dehydrogenases, the sirtuins have evolved an additional set
of catalytic residues that are not found in any of these
dehydrogenases.34,35,92 The acquisition of these residues
probably resulted in an ancestral NAD-binding Rossmann
dehydrogenase giving rise to the sirtuins, which instead utilized
NAD as a substrate to transfer ADP-ribose to target moieties.
Together, these observations imply that sirtuins are likely to have
been one of the ﬁrst NAD-dependent ADP-ribosyltransferases.
Similarly, independent transitions of NAD-cofactor dependent
redox enzymes to NAD-utilizing adenylating enzymes appear
to have also happened in the post-LUCA radiation of the
Rossmann fold evolution as indicated by the Thi4-like enzymes,
which utilize NAD as a substrate in the synthesis of thiamine.95,96
In the post-LUCA phase other structurally unrelated enzymes
utilizing NAD as a substrate, rather than as a redox cofactor,
emerged early in the evolution of either the bacterial or the
archaeal lineage. In the bacterial lineage nucleic acid ligases with
the ATP-grasp fold appear to have evolved the ability to utilize
NAD for adenylating phosphate moieties at the ends of nucleic
acid as an intermediate in the ligation of DNA.49,97 The archaeo-
eukaryotic lineage displays several universally conserved RNA-
processing enzymes, such as RNA 20-phosphotransferase
(KptA), RNA 30-cyclase, 2H superfamily cyclic phospho-
diesterases, and Thg1 polymerases.63,98,99 In contrast, these are
only sporadically distributed in bacteria and may not co-occur
as a group in the bacteria that possess them. Hence, it appears
likely that these arose ﬁrst in the archaeo-eukaryotic lineage as
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components of their unique tRNA processing systems, which
were subsequently transferred to bacteria and utilized in RNA
repair. Unlike KptA, in the archaeo-eukaryotic lineage,
bacteria do not show any widely conserved version of the
ART fold that can be traced to their common ancestor. Hence,
it appears that the ART fold ﬁrst emerged in the archaeo-
eukaryotic lineage in the form of KptA as a structurally
distinct NAD-utilizing ADP ribosyltransferase. The observa-
tions reported above suggest that following the transfer of
KptA-like enzymes to bacteria, these NAD-utilizing systems
underwent extensive diversiﬁcation in the bacterial lineage.
This process involved the innovation and recruitment of
additional enzymes, such as the NADAR, ARG and Macro
domains, which further processed NAD-derived products
generated by the action of KptA in the context of RNA repair.
Importantly, the prediction of a novel ART of the H–Y–E
clade (i.e. the BC4486) that functions in conjunction with the
NADAR, Macro or ARG domains, when combined with the
above observations, has general implications for understanding
the further evolution of NAD-utilizing systems. The system
deﬁned by this ART adds to the diversity of potential NAD-
utilizing protein-modifying ARTs that are analogs of the
DraT–DraG system.25–27,100 The newly identiﬁed BC4486-like
ARTs retain the same form of the ﬁrst and second catalytic
motifs as KptA, while acquiring an acidic residue in the third
position. This, together with the archaeo-eukaryotic origin of
the ART fold, suggests that protein-modifying ARTs ﬁrst
emerged as a part of the bacteria-speciﬁc radiation of this fold,
and the BC4486-like ARTs possibly represent an intermediate
in this transition. The BC4486-like ART-containing systems,
which we have uncovered in this study are sporadically
distributed across a wide phylogenetic range of bacteria, and
their cores are comprised of a dyad of proteins that respec-
tively add and remove ADP-ribose modiﬁcations from target
proteins. This genomic organization, which is comparable to
type II toxin–antitoxin systems, suggests that protein-modifying
ARTs perhaps emerged as components of mobile, potentially
selﬁsh, toxin–antitoxin-like systems that were on occasions
recruited as regulatory switches.72 This situation may also be
compared to the polymerase b-fold nucleotidyltransferases that
exist both as protein-modifying regulatory systems (e.g. the
protein uridylyl transferase GlnD) and the mobile small
nucleotidyltransferases. The genes for the latter enzymes always
co-occur with an associated ORF, in type-II toxin–antitoxin
like gene dyads, with the products of their associated ORFs
potentially removing nucleotidyl modiﬁcation that they
catalyze.101 In course of this diversiﬁcation, the ARTs also
appear to have acquired a wider substrate range in terms of
target residues with modiﬁcations to the active site (e.g. emergence
of the R–S–E clade of ARTs).16–21,31,47 This diversiﬁcation of
ARTs of the R–S–E clade appears to have followed two distinct
courses: (1) in elements resembling type-II toxin–antitoxin-like
systems, such as the previously described DraT–DraG-like
systems. (2) In the newly discovered class of elements deployed
in intra-species conﬂicts (such as those described above),
wherein the ART toxin is translocated to the cell surface
and delivered via contact or through injection by the type VI
secretory system into target cells. Some versions of the latter type
appear to have been further adapted in inter-species conﬂict,
in particular in pathogenic bacteria as toxins directed against
their eukaryotic hosts. This bacterial diversiﬁcation of the
protein-modifying ARTs both in the context of intra-genomic
conﬂicts (i.e. type II toxin–antitoxin-like systems) and inter-
organism conﬂict (i.e. toxin ARTs delivered to target cells)
appears to have also provided a niche for the emergence and
diversiﬁcation of antitoxins or immunity proteins that would
reverse the modiﬁcations catalyzed by the toxin ARTs. It was
in this context that several enzymes such as the BC4488-like
NADAR domains and diﬀerent ADP ribosylglycohydrolases
(including the MACRO domain versions, PARGs and the
classical ARGs) appear to have emerged and radiated. The
extraordinary expansion of such toxin systems in bacteria,
along with the selective pressures due to emerging resistance
and immunity proteins provided extensive opportunities for the
diversiﬁcation of ART toxins in such systems. As a consequence,
ARTs with highly specialized targets against which resistance is
diﬃcult to develop, such as diphthamide and bases in DNA,
emerged in such systems. Additionally, ART domains were also
recruited as neutralizing enzymes for antibiotics deployed in
inter-speciﬁc conﬂicts among bacteria.16–21,31,47
Eukaryotes appear to have acquired and recruited these
components from the above-described bacterial radiation of the
NAD-dependent systems on several independent occasions.
The shared H–Y–E active site conﬁguration in the BC4486-like
ARTs, diphthamide-speciﬁc ARTs and PARPs suggests that
the latter could have potentially emerged from a BC4486-like
ART from a toxin–antitoxin-like system or a related version.
Indeed, we have detected several bacterial homologs of PARPs
as toxin domains among the versions of the recently described
polymorphic toxin systems32,70 (e.g. gi: 291451874 from
Streptomyces albus), suggesting that they probably arose as
part of the radiation of toxin systems in bacteria. Such a
PARP precursor and also certain sirtuins appear to have been
already acquired prior to the last eukaryotic common ancestor,
perhaps from endosymbiotic bacteria, giving rise to the histone-
deacetylation and polyADP-ribosylation systems seen in
eukaryotes.94,102 Further Sirtuin, Macro, NADAR, NUE,
and ART domains appear to have also been repeatedly
acquired by eukaryotes in their subsequent evolution and
incorporated into diverse functional systems distinct from
those of the ancestral bacterial versions. The NEURL4 clade
of BC4486-related ARTs represents a potential independent
transfer that probably happened well after the last-eukaryotic
common ancestor but prior to divergence of several major
eukaryotic lineages, such as opisthokonts and alveolates. In
the case of ARTs, new acquisitions from toxin genes of
symbiotic or parasitic bacteria appear likely. Indeed, some of
the eukaryotic versions are deployed in a functional capacity
similar to the original toxins (e.g. induction of apoptosis by
pierisin-like ARTs in insects23). Given the genomic linkage
between ARTs and ARGs in several of the bacterial gene
neighborhoods described in this work, transfer of an entire gene
cluster from bacteria in a single event could have potentially
supplied both the enzyme that generates and removes the
modiﬁcation transfer, thereby enabling their recruitment as a
regulatory switch. Phylogenetic analyses of the YbiA and BC4488
clades of the NADAR superfamily, as well as the NUE domain,
despite uncertainties arising from rapid sequence divergence,
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also tend to support a picture with multiple independent transfers
of these domains to eukaryotes (ESIw).
On a more general note, our observations suggest that the
NAD-dependent biopolymer-modifying enzymes display an
evolutionary pattern comparable to that seen in the ubiquitin
and the ATP-grasp and glutamine synthetase-like COOH–NH2
ligase-dependent protein modifying systems: in all these cases
the initial enzymatic components arose as part of core bio-
synthetic pathways. Subsequent radiations, particularly in bacteria,
spawned paralogous versions with more diversiﬁed targets
and regulatory capabilities, often as components of systems
deployed in secondary metabolism and inter-genomic conﬂict
in bacteria.1,2,7 These were then acquired by eukaryotes and
incorporated into their functional systems in ways entirely
diﬀerent from their original bacterial roles. We hope that the
novel ﬁndings and hypotheses presented here (Table 1) will
inspire further biochemical investigations that might lead to a
better understanding of diverse NAD-dependent systems.
Materials and methods
Sequence proﬁle searches were performed against the NCBI non-
redundant (NR) database of protein sequences (National Center
for Biotechnology Information, NIH, Bethesda, MD), and a
locally compiled database of proteins from eukaryotes with
completely or near-completely sequenced genomes. PSI-BLAST103
searches were performed using an expectation value (e-value) of
0.01 as the threshold for inclusion in the position-speciﬁc scoring
matrix generated by the program; searches were iterated until
convergence. Structure similarity searches and alignments were
obtained using the DALI program.104 Protein structures were
visualized and manipulated using the PyMol (http://pymol.
sourceforge.net/) program. Multiple alignments were constructed
using the Kalign program,105 followed bymanual correction based
on PSI-BLAST high-scoring pairs, secondary structure predictions,
and information derived from existing structures. Protein
secondary structure was predicted using a multiple alignment as
the input for the JPRED2 program,106 which uses information
extracted from a PSSM, HMM, and the seed alignment itself.
Pairwise comparisons of HMMs, using a single sequence or
multiple alignment as query, against proﬁles of proteins in the PDB
database were performed with the HHPRED program.107,108
Similarity-based clusteringwas performed using the BLASTCLUST
program [ftp://ftp.ncbi.nih.gov/blast/documents/blastclust.html]
with empirically determined length and score threshold parameters.
Maximum likelihood phylogenetic trees were inferred using the
programFastTree109 with default parameters. Gene neighborhoods
in prokaryotes were obtained by isolating conserved genes imme-
diately upstream and downstream of the gene in question showing
separation of less than 70 nucleotides between gene termini.
Neighborhoods were determined by searching NCBI PTT tables
(http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=Genome) with
a custom PERL script. All large-scale procedures were carried
out using the TASS software package.
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